TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer

被引：0

作者：

D. Ferraro

D. Goldstein

R. L. O’Connell

J. R. Zalcberg

K. M. Sjoquist

N. C. Tebbutt

P. Grimison

S. McLachlan

L. L. Lipton

P. Vasey

V. J. Gebski

C. Aiken

M. Cronk

S. Ng

C. S. Karapetis

J. Shannon

机构：

[1] University of Sydney,National Health and Medical Research Council Clinical Trials Centre

[2] University of New South Wales,Prince of Wales Clinical School

[3] Monash University,Department of Epidemiology and Preventive Medicine

[4] Austin Health,Haematology and Oncology Clinics of Australasia

[5] Chris O’Brien Lifehouse,Department of Medical Oncology

[6] St Vincents Hospital,Department of Pathology

[7] University of Melbourne,undefined

[8] Western Health,undefined

[9] Wesley Medical Centre,undefined

[10] Nambour General Hospital,undefined

[11] Flinders University,undefined

[12] Nepean Cancer Care Centre,undefined

[13] University of Melbourne,undefined

[14] Sir Charles Gairdner Hospital,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2016年 / 78卷

关键词：

Biliary tract cancer; KRAS; Panitumumab; Chemotherapy; Phase II trial; Cancer antigen 19.9;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：361 / 367

页数：6

共 50 条

[31] Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E. Chaft
Filiz Oezkan
Mark G. Kris
Paul A. Bunn
Ignacio I. Wistuba
David J. Kwiatkowski
Dwight H. Owen
Yan Tang
Bruce E. Johnson
Jay M. Lee
Gerard Lozanski
Maciej Pietrzak
Michal Seweryn
Woo Yul Byun
Katja Schulze
Alan Nicholas
Ann Johnson
Jessica Grindheim
Stephanie Hilz
David S. Shames
Chris Rivard
Eric Toloza
Eric B. Haura
Ciaran J. McNamee
G. Alexander Patterson
Saiama N. Waqar
Valerie W. Rusch
David P. Carbone
Nature Medicine, 2022, 28 : 2155 - 2161
[32] Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Boye, Kjetil
Longhi, Alessandra
Guren, Tormod
Lorenz, Susanne
Naess, Stine
Pierini, Michela
Taksdal, Ingeborg
Lobmaier, Ingvild
Cesari, Marilena
Paioli, Anna
Londalen, Ayca M.
Setola, Elisabetta
Hompland, Ivar
Meza-Zepeda, Leonardo A.
Hall, Kirsten Sundby
Palmerini, Emanuela
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2617 - 2624
[33] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
Lan, Chunyan
Huang, Xin
Shen, Jing-Xian
Wang, Yin
Xiong, Ying
Li, Jundong
Cao, Xinping
Deng, Yanhong
He, Mian
Zou, Guorong
Wang, Xiaodi
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[34] Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Chaft, Jamie E.
Oezkan, Filiz
Kris, Mark G.
Bunn, Paul A.
Wistuba, Ignacio I.
Kwiatkowski, David J.
Owen, Dwight H.
Tang, Yan
Johnson, Bruce E.
Lee, Jay M.
Lozanski, Gerard
Pietrzak, Maciej
Seweryn, Michal
Byun, Woo Yul
Schulze, Katja
Nicholas, Alan
Johnson, Ann
Grindheim, Jessica
Hilz, Stephanie
Shames, David S.
Rivard, Chris
Toloza, Eric
Haura, Eric B.
McNamee, Ciaran J.
Patterson, G. Alexander
Waqar, Saiama N.
Rusch, Valerie W.
Carbone, David P.
NATURE MEDICINE, 2022, 28 (10) : 2155 - +
[35] Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma
Schwartzberg, Lee
Hermann, Robert
Flinn, Ian
Flora, Douglas
Hsi, Eric D.
Hamid, Oday
Shi, Peipei
Lin, Boris K.
Myrand, Scott P.
Nguyen, Tuan S.
Dreyling, Martin
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (01) : 91 - 97
[36] AFATINIB COMBINED WITH GEMCITABINE/CISPLATIN IN CHEMOTHERAPY NAIVE PATIENTS WITH ADVANCED BILIARY TRACT CANCER: RESULTS AND TRANSLATIONAL ANALYSIS OF AN OPEN-LABEL, PHASE I TRIAL
Thomaidis, Thomas
Maderer, Annett
Schad, Arno
Ruckes, Christian
Weinmann, Arndt
Sivanathan, Visvakanth
Marquardt, Jens U.
Foerster, Friedrich
Galle, Peter R.
Woerns, Marcus
Moehler, Markus
GASTROENTEROLOGY, 2019, 156 (06) : S1047 - S1047
[37] Safety and efficacy of Afatinib with Gemcitabine/Cisplatin in chemo-naive patients with metastatic biliary tract cancer: An open-label, uncontrolled phase Ib trial
Moehler, M.
Ehrlich, A.
Ruckes, C.
Thomaidis, T.
Weinmann, A.
Galle, P. R.
Woerns, M. A.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S440 - S440
[38] Effects of resveratrol on aortic growth in patients with Marfan syndrome: a single-arm open-label multicentre trial
van Andel, Mitzi Marlotte
Bosshardt, Daan
Schrauben, Eric M.
Merton, Renske
van Kimmenade, Roland R. L.
Scholte, Arthur
Dickinson, Michael G.
Robbers-Visser, Danielle
Zwinderman, Aeilko H.
Mulder, Barbara
Nederveen, Aart J.
van Ooij, Pim
Groenink, Maarten
de Waard, Vivian
HEART, 2024,
[39] A phase II, open-label, single-arm trial of pembrolizumab for refractory atypical and anaplastic meningioma and hemangiopericytoma.
Yust-Katz, Shlomit
Amiel, Alexandera
Siegal, Tali
Limon, Dror
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[40] Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial
Jin, Shuiling
Zhao, Ruihua
Zhou, Chuang
Zhong, Qian
Shi, Jianxiang
Su, Chang
Li, Qinglong
Su, Xiaoxing
Chi, Huabin
Lu, Xu
Jiang, Guozhong
Chen, Renyin
Han, Jinming
Jiang, Miao
Qiao, Shishi
Liu, Jingjing
Song, Min
Song, Lijie
Du, Yabing
Chang, Zhiwei
Wang, Meng
Dong, Meilian
Zhong, Yali
Yu, Pu
Zhang, Xiaojian
Zong, Hong
INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (08) : 1648 - 1658

← 1 2 3 4 5 →